7 Results for "

APOBEC3G

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "APOBEC3G" in MCE Product Catalog:

Cat. No.: HY-W279260
CAS No.: 14261-92-8
Target:  

HIV

Research Areas:  

Infection

APOBEC3G-IN-1 (MN136.0154) is a potent HIV inhibitor, targeting APOBEC3G .
loading...
    loading...
Cat. No.: HY-148138
CAS No.: 397878-17-0
Purity:  99.64%
Target:  

HIV

Research Areas:  

Infection

Deaminase inhibitor-1 is a small molecule inhibitor of APOBEC3G DNA Deaminase, with an IC50 value of 18.9 μM .
loading...
    loading...
Cat. No.: HY-RS00840
Research Areas:  

Others

APOBEC3G Human Pre-designed siRNA Set A contains three designed siRNAs for APOBEC3G gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-122156
CAS No.: 64009-84-3
Purity:  99.08%
Target:  

HIV

Research Areas:  

Infection

IMB-301 is a specific HIV-1 replication inhibitor that binds to hA3G (human APOBEC3G), interrupts the hA3G-Vif interaction and inhibits Vif-mediated degradation of hA3G. IMB-301 inhibits the replication of HIV-1 in H9 cells (IC50=8.63 uM). Human APOBEC3G is a restriction factor that inhibits human immunodeficiency 1 virus (HIV-1) replication .
loading...
    loading...
Cat. No.: HY-148042
CAS No.: 137448-39-6
Purity:  ≥98.0%
Target:  

HIV

Research Areas:  

Infection

HIV-1 inhibitor-47 is an inhibitor of HIV-1, and inhibits vif-dependent degradation of human APOBEC3G, with an IC50 value of 14.33 μM. HIV-1 inhibitor-47 also involves in derivatives of 1-(2-pyrimidinyl)piperazine synthesis, with potential antianxiety, antidepressant, and antipsychotic effect [3].
loading...
    loading...
Cat. No.: HY-124870
CAS No.: 357441-99-7
Target:  

HIV

Research Areas:  

Infection

N.41 is an antiviral agent. N.41 protects APOBEC3G (an antiviral factor) from HIV Vif protein-mediated degradation. N.41 inhibits the Vif-A3G interaction and increases cellular A3G levels and incorporation of A3G into virions, thereby attenuating virus infectivity in a Vif-dependent manner. N.41 inhibits HIV-1 viral replication in PBMCs (IC50: 8.4 μM) .
loading...
    loading...
Cat. No.: HY-183925
CAS No.: 52962-95-5
Research Areas:  

Infection

Redoxal is a dihydroorotate dehydrogenase (DHODH) inhibitor and anti-HIV-1 agent. Redoxal induces intracellular pyrimidine depletion by inhibiting the de novo pyrimidine biosynthesis pathway, enhances the protein stability of APOBEC3G (A3G), upregulates the abundance of A3G protein in cells and progeny viral particles, thereby strengthening the host endogenous antiviral restriction mediated by A3G . Redoxal selectively targets DHOdehase at the mitochondrial level, with an IC50 of 430 nM for inhibiting DHO oxidation in human mitochondria and an IC50 of 910 nM in rat mitochondria . Redoxal can be used in studies related to HIV-1 infection .
loading...
    loading...